North America

Mon
04
Mar

Why marijuana stock GW Pharmaceuticals jumped 20.5% in February

What happened

GW Pharmaceuticals (NASDAQ:GWPH) stock jumped 20.5% last month, according to data from S&P Global Market Intelligence. It tacked on another 3.1% on Friday, the first day of March.

The British biopharmaceutical company develops prescription drugs derived from cannabinoids, chemical substances found in marijuana.

For context, the S&P 500 index returned 3.2% in February.

Mon
04
Mar

Here are some mistakes people make with cannabis so you don't have to learn the hard way

Have you ever underestimated the potency of your weed and gotten way too freaking high? It’s a common experience that may be on the rise for a couple of reasons, writes Danielle Simone Brand. As more and more states legalize adult-use cannabis, the ranks of the canna-curious are growing. And while many newbies are educating themselves — using the internet, budtenders and seasoned consumers as resources — others don’t have enough information before jumping in.

Mon
04
Mar

NHL Alumni Association strikes deal with cannabis company for medical exams, brain scans

The NHL Alumni Association has signed a landmark agreement with Canopy Growth Corp., that will see the Canadian cannabis company finance one or more studies that could be an important step towards establishing the first comprehensive snapshot of the health of retired hockey players.

Canopy Growth has agreed to cover the costs of a double blind randomized study, which will involve about 100 former players in the Toronto area and take about a year to produce results, according to a person familiar with the matter.

The study will explore whether cannabinoids might help to wean former players off of addictive opioids. If the results of the initial study are encouraging, Canopy Growth has agreed to fund a second study of former players with more subjects.

Mon
04
Mar

Will pot patches make this marijuana stock soar?

The marijuana industry has taken the investing world by storm, and cannabis stocks have soared so far in 2019. Rising demand from the legalization of recreational cannabis in Canada has been a huge growth opportunity, and as more states in the U.S. join the legal marijuana movement, the industry continues to gain momentum.

Mon
04
Mar

The amazing link between CBD and PTSD

When one thinks about the psychological landscape of contemporary America, stories of PTSD and disturbing behavior abound. Furthermore, through the mass media, the people of the United States are continuously inundated images of violence, sickness, and despair. Looking at these notions with a critical eye, there is an underlying string of connectivity between mental illness and its subsequent manifestations in violent acts.

Mon
04
Mar

Why this marijuana stock's US debut was a bust

2019 has been a great year for marijuana stocks so far, as investors are fully jumping into the bullish camp for the expansion of the cannabis industry over the long run. With many well-known cultivation companies reporting big ramp-ups in revenue thanks in large part to the late-2018 opening of the Canadian recreational cannabis market, the potential for further sales gains seems limitless.

Thu
28
Feb

Marijuana stocks have cost traders betting against them nearly $200 million in February (CGC, ACB, CRON, TLRY)

  • Short sellers betting against weed stocks have lost nearly $200 million in February, according to data from S3 Partners, a financial-analytics firm.
Thu
28
Feb

Worried about pesticides in cannabis? Growing organic may offer peace of mind

Over the years, there have been a handful of scientific studies published detailing the presence of pesticides, industrial solvents, growth regulators, heavy metals, bacteria and other potentially hazardous contaminants in commercially available cannabis products.

Thu
28
Feb

Aphria and Manna Molecular Science ink licence agreement on cannabis transdermal patches

Aphria Inc. has reached a worldwide licence agreement with Manna Molecular Science, LLC regarding the latter company’s state-of-the-art cannabis transdermal patches.

“Under the agreement, Manna grants Aphria exclusive preferred vendor status for a period of five years, and an exclusive licence to produce, market, distribute, promote and sell Manna patches containing cannabis oil as an active ingredient,” notes a statement from Leamington, Ont.-headquartered Aphria, a global cannabis company.

Thu
28
Feb

Millennial investors: Is Aurora Cannabis Inc. (TSX:ACB) or Canopy Growth Corp. (TSX:WEED) the better marijuana stock?

Investing in marijuana stocks is not for the faint of heart.

It is a move that requires nerves of steel and a willingness to look through the speculation and lofty valuations as a cost of gaining exposure to the upside in this massive industry.

For millennial investors, you have time on your side.

That’s a very good thing because it will take a lot of time for marijuana stocks to grow into their valuations.

Pages

Subscribe to RSS - North America